Assessment of TNF Frequency in Human Patients with Multiple Sclerosis
The study aims to assess the frequency of TNF and the determinants of functional neurological disorders in patients with multiple sclerosis. Eligible patients at two centers in France will be invited to participate during medical visits, with the goal to recruit enough participants within a year.
- Tags
- #MSResearch
- Most relevant to
- —
- Source
- Read original source
Why it matters
Understanding the frequency of TNF in multiple sclerosis patients may help clarify the role of inflammation in the disease and its related disorders.
What this does not prove
No results are posted, and planned enrolment and endpoints do not constitute findings. Thus, the study's outcomes remain unknown.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
Supporting passages (4)
subjects"studyPopulation": "During a routine medical visit, eligible patients will be informed about the study and invited to participate.\n\nThe two participating centers, located in Strasbourg and Nancy, each have an active cohort allowing the required number of participants to be recruited within one year.",
primary endpoint"description": "Assessment of the frequency of TNF in patients with multiple sclerosis",
findings"officialTitle": "Assessment of the Frequency of Functional Neurological Disorders in Multiple Sclerosis and Analysis of Clinical and Psychological Determinants: A Multicenter Cross-Sectional Study",
limitationsNo results are posted. Planned enrolment and endpoints are not findings.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.